Genoveva
Yagüe Guirao
Publicaciones en las que colabora con Genoveva Yagüe Guirao (12)
2023
-
The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)
Frontiers in Microbiology, Vol. 14
2016
-
Compendio de microbiología
Elsevier
2015
-
Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method
Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 11, pp. 6725-6732
2014
-
Prevalence of plasmid-mediated quinolone resistance determinants in extended-spectrum β-lactamase-producing and -non-producing enterobacteria in Spain
International Journal of Antimicrobial Agents
2012
-
Comparison of three statistical methods for establishing tentative wild-type population and epidemiological cutoff values for echinocandins, amphotericin B, flucytosine, and six Candida species as determined by the colorimetric sensititre yeastone method
Journal of Clinical Microbiology, Vol. 50, Núm. 12, pp. 3921-3926
2011
-
Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia
Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 12, pp. 5590-5596
2003
-
In vitro activity of newer antibiotics against Corynebacterium jeikeium, Corynebacterium amycolatum and Corynebacterium urealyticum
International Journal of Antimicrobial Agents, Vol. 22, Núm. 5, pp. 492-496
2002
-
Effiux-mediated antibiotic resistance in Gram-positive bacteria
Reviews in Medical Microbiology, Vol. 13, Núm. 1, pp. 1-13
-
In vitro activity of linezolid, synercid and telithromcin against genetically defined high level fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus
International Journal of Antimicrobial Agents, Vol. 20, Núm. 1, pp. 61-64
2001
-
Molecular diversity of quinolone resistance in genetically related clinical isolates of Staphylococcus aureus and susceptibility to newer quinolones
Journal of Antimicrobial Chemotherapy, Vol. 47, Núm. 2, pp. 157-161
2000
-
Actividad de nuevas quinolonas frente a aislamientos clinicos de Corynebacterium spp
Revista Espanola de Quimioterapia, Vol. 13, Núm. 3, pp. 267-270
1999
-
In vitro activities of 13 fluoroquinolones against Staphylococcus aureus isolates with characterized mutations in gyrA, gyrB, grlA, and norA and against wild-type isolates
Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 4, pp. 966-968